Psilocybin Plus Psychotherapy Offers Lasting Benefit in Cancer, Depression
About half of patients had sustained reduction in depression and anxiety up to two years after psilocybin and psychotherapy
Texas Invests $50M in Psychedelic Drug Research to Treat Addiction
Doctors’ Preferences for Their Own End-of-Life Care? No Life-Sustaining Practices
About half of physicians would consider euthanasia as a good or very good option in a scenario of advanced cancer or Alzheimer disease
New Mothers Face Significant Loss of Uninterrupted Sleep
Findings show uninterrupted sleep deficit persists longer than lower sleep duration
Shorter Leukocyte Telomere Length Linked to Higher Incidence of Age-Related Brain Diseases
Shorter leukocyte telomere length linked to higher incidence rates of stroke, dementia, late-life depression as composite and individually
Talking Therapy Reduces Depression, Anxiety Symptoms in Stroke Survivors
Patients who start attending services a year or more after stroke less likely to recover from symptoms of depression, anxiety
988 Contacted More Than 16 Million Times From Its Launch to December 2024
Past-year contact incidence rate was 23.7 per 1,000 population and past-year 988 use prevalence was 1.6 percent
Attrition Rates High Among Lesbian, Gay, Bisexual Medical Students
Highest odds of attrition were seen among LGB Hispanic male and female students
Daytime Napping Behaviors in Middle-Aged, Older Adults Impact Mortality Risk
Increased mortality seen in association with longer nap duration, greater intraindividual variability, more naps from 11 a.m. to 1 p.m., 1 to 3 p.m.
Almost One-Quarter of U.S. Firearm Suicides May Occur Outside the Home
Higher percentage of male versus female decedents as well as more Asian or Pacific Islander and Black versus White decedents die outside the home
